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Inducer T  cells initiate virtually all humoral and cellular immune responses. These 
cells "corecognize" a  complex composed of antigen and class II major histocompati- 
bility complex (MHC) x products. However, the interaction between the receptor and 
the antigen/class II product complex (ligand) is poorly understood. A major difficulty 
has been the use of antigens consisting of peptides or polymers that carry an unknown 
number and type of determinants that can form immunogenically active complexes 
with I-A. 
Production  of monoclonal T  cells that corecognize a  single defined determinant, 
such as a  hapten,  in association with class II MHC  products allows direct  biologic 
and biochemical definition of this interaction. We therefore developed two series ofT 
cell clones that recognize the haptens 2,4,6-trinitrophenyl  (TNP)  and  (4-hydroxy-3- 
nitrophenyl) aeetyl (NP). These haptens, together with a panel of structural analogues 
that differ in the degree and position of substitution  on the phenyl ring, define the 
precise chemical composition of the nominal antigen portion of ligand recognized by 
inducer cell clones. 
We show that inducer T  cell clones can be divided into two broad groups based on 
their specificity. The first and by far the largest group is termed "conjugate specific": 
these clones are activated only by hapten conjugated to the same carrier protein that 
was  used  for  in  vitro  selection.  The  second  group  is  rare.  These,  termed  "hapten 
specific,"  are  activated  by  hapten  coupled  to  all  foreign  and  autologous  proteins 
tested, as well as by hapten coupled to cells. The specificity of these clones for hapten 
is extremely precise, and they cannot be activated by proteins coupled to very closely 
related hapten analogues. Both types of clones corecognize soluble antigen in associ- 
ation with products of the I-A locus. Analysis of the response of hapten-specific clones 
* Supported by National Institutes of Health grants AI  13600, CA26695, and A112184. 
* Fellow of the Muscular Dystrophy Association. 
0 Special Fellow of the Leukemia Society  of America. 
1 Abbreviations used in this paper:  APC, antigen-presenting cell; BGG, bovine gamma globulin; BSA, 
bovine serum albumin; CGG, chicken gamma globulin; Con A, concanavalin A;  DME, Dulbeeco's 
modified Eagle's medium; DNBS, dinitrobenzene sulfonic acid; DNP, 2,4-dinitrophenyl; FITC, fluores- 
ceinisothioeyanate; GLA, L-glutamic acid-L-lysine-L-alanine;  GLLeu, L-glutamic acid-L-lysine-L-leucine; 
GLO, L-glutamic  acid-L-lysine-L-phenylalanine;  GLT, L-glutamic  acid-L-lysine-L-tyrosine;  IL-2, interleukin 
2; Ir, immune response; KLH, keyhole  limpet hemocyanin; MHC, major histocompatibility  complex; MIg, 
mouse immunoglobulin; MSA, mouse serum albumin; NIP, (4-hydroxy-5-iodo-3-nitrophenyl)  aetyl; NP, 
(4-hydroxy-3-nitrophenyl) acetyl; OVA, ovalbumin; TA, turkey albumin; TNBS, trinitrobenzene sulfonic 
acid; TNP, 2,4,6-trinitrophenyl. 
1906  J. ExP. MEn. © The Rockefeller  University Press • 0022-1007/83/06/1906/14 $1.00 
Volume 157  June 1983  1906-1919 CLAYBERGER  ET  AL.  1907 
allowed definition of the molecular basis of I-A vs.  I-E gene control and the role of 
inducer cell specificity in activating responses to foreign and autoantigens. 
Materials  and  Methods 
Animals.  The recombinant strains B10.G, B10.RIII, B10.PL, B10.S, C3H.LG, and D2.GD 
were kindly donated by Dr. M. Dorf (Harvard Medical School, Boston, MA). A/J, C57BL/6, 
C57BL/10  (B10),  BALB/c, B10.A(SR), B10.BR,  and B10.D2  mice were obtained from The 
Jackson  Laboratory, Bar  Harbor,  ME.  B10.A(3R)  and  B10.A(4R)  mice were  bred  in  the 
Michael Redstone Animal Facility of the Sidney Farber Cancer Institute from breeding pairs 
donated by Dr. D. Murphy, Yale University School of Medicine and by Dr. D. Sachs, National 
Institutes of Health. 
Antigens.  NP and (4-hydroxy-5-iodo-3-nitrophenyl) acetyi (NIP) conjugates were prepared 
using NP-O-succinimide and NIP-O-succinimide (Biosearch, San Rafael, CA) according to the 
method of Weinberger et al.  (1).  TNP  and  2,4-dinitrophenyl (DNP)  conjugates were made 
using 2,4,6-trinitrobenzene sulfonic acid (TNBS) and 2,4-dinitrobenzene sulfonic acid (DNBS) 
according to the method of Eisen et al. (2). Fluoresceinisothiocyanate (FITC) conjugates were 
prepared from fluoresceinisothiocyanate as described elsewhere (3). Ovalbumin (OVA), bovine 
gamma  globulin (BGG), keyhole limpet hemocyanin  (KLH), turkey albumin  (TA), bovine 
serum  albumin  (BSA), mouse  serum  albumin  (MSA), mouse  immunoglobulin  (MIg),  and 
chicken gamma globulin (CGG) were haptenated to final conjugation ratios of NPx0-OVA, 
NIPls-OVA, NP26-BGG, NP12-KLH, NPls-TA, TNPIs-OVA, TNPas-BSA, TNPs0-BGG; TNP21- 
KLH, TNP20-MSA, TNP,o-MIg, NP~-CGG, DNPs-OVA, DNP~-BGG, DNPls-MSA, FITC10- 
OVA, and FITCs2-BGG. The synthetic polypeptides used in these studies were the gift of Dr. 
M. Dorf. 
Antisera.  Monoclonal anti-Ly-1, anti-Ly-2, and  anti-Thy-1  were  purchased  from  Becton 
Dickinson  (Mountain  View,  CA).  Expression  of surface  glycoproteins by  each  clone  was 
determined by immunofluorescence as described previously (4). 
Anti-TNP and anti-NP antisera were prepared from ascites of mice immunized with TNP- 
BSA or NP-KLH according to the method of Tung et al. (5) and affinity purified on TNP- 
BGG- or NP-OVA-coupled Sepharose 4B columns. 
Cells of the hybridomas 14.4.4S  (I-Ea'k'P~), MKD6 (I-Ad'q), and 34.5.3  (I-Ab'd'P'q), (6, 7) were 
grown in RPMI  1640 supplemented with 10% fetal calf serum. Antibodies were purified from 
culture supernatants by DEAE cellulose chromatography. 
Preparation of Haptenated Cells.  Spleen cells were  irradiated (2,000  rad)  and  treated with 
ammonium chloride to lyse the erythrocytes. Spleen cells were coupled with NP-O-succinimide 
or NIP-0-succinimide according to the method of Weinberger et al.  (1).  TNP-coupled cells 
were prepared by incubating 5  ×  10  v cells/ml with an  equal volume of 20  mM  TNBS  in 
phosphate-buffered saline, pH 7.4, at 37°C. DNP- and FITC-coupled cells were prepared by 
incubating 5  ×  107 cells/ml with an equal volume of 20 mM  DNBS  or 0.25  mM  FITC in 
phosphate-buffered saline, pH 9.0, for 15 min at 37 °. Cells were washed extensively before use. 
Preparation of Conditioned Medium.  BALB/c  spleen  cells  (5  ×  106/ml)  were  cultured  in 
Dulbecco's modified Eagle's medium (DME)  (Gibco Laboratories, Grand Island, NY) supple- 
mented  with  arginine,  asparagine,  folic acid,  nonessential  amino  acids,  sodium  pyruvate, 
essential amino aids, 5  ×  10  -5 M  2-mercaptoethanol, and  2  mM  glutamine. Cultures were 
stimulated with 2 #g/ml concanavalin A  (Con A) (Calbiochem-Behring Corp., La Jolla, CA) 
and incubated for 18 h  at 37°C in  10% CO2.  Cell-free supernatants from these cultures were 
depleted of residual Con A by passage over a DEAE cellulose column, filtered, and stored at 
-20°C until use. This preparation is designated interleukin 2 (IL-2). 
Derivation of Clones 
CL.LY1-Tt.  BALB/c mice were immunized with 50 #g TNPls-BSA in complete Freund's 
adjuvant in all footpads. 5 d later, the axillary and inguinal lymph nodes were removed and a 
single cell suspension was prepared by gentle teasing. Cells were cultured in the absence of 
exogenous  IL-2  in  DME  containing  10%  fetal  calf serum  (Gibco  Laboratories)  and  were 
stimulated weekly with TNPs0-BGG-pulsed, irradiated (2,000 rad) peritoneal macrophages (106 1908  TWO  CLASSES OF  HAPTEN-REACTIVE INDUCER  CELLS 
macrophages/107 lymph node cells). No additional soluble antigen was used to supplement 
stimulation (see below). Cultures were supplemented with fresh medium (DME,  10% fetal calf 
serum, 4 mM glutamine, 5 ×  10  -5 M  mercaptoethanol [CDME]) every other day and cloned 
after 3-4 wk as described below. 
CL.LYI-NS.  C57BL/6 mice were immunized at the base of the tail and in the hind footpads 
with 50/~g NP12-KLH in complete Freund's adjuvant. 5 d later the draining lymph nodes were 
removed and a single cell suspension was cultured with NPaa-OVA as described above except 
that (a) irradiated syngeneic spleen cells (2,000 rad) were used as a source of antigen-presenting 
cells  (APC)  and  (b)  100  /~g  of soluble,  rather  than  cell-bound,  "pulsed"  NP-OVA  was 
periodically added to cultures. 
CL.LVl-T3.  BALB/c mice were immunized in all four footpads with 50/zg TNP2a-BSA in 
complete Freund's adjuvant. 5 d  later the axillary and inguinal lymph nodes were removed 
and cells were cultured as for CI.Lyl-T1 except that TNP25-BGG was used instead of TNPs0- 
BGG. 
CL.LVI-N1.  C57BL/6 mice were immunized in the tail vein with 107 NP-coupled syngeneic 
spleen cells. 5 d later the spleens were removed and a single cell suspension was incubated with 
irradiated  (2,000  rad)  NP-eoupled syngeneie cells in  CDME  with  no  IL-2. Cultures  were 
stimulated weekly with NP-coupled syngeneic cells and cloned after 3-4 wk as described below. 
CL.LYI-T6.  BALB/c mice were immunized in the tail base and footpads with TNP-coupled 
syngeneic spleen cells. 5  d  later the  draining lymph  nodes  were  removed,  incubated  with 
irradiated (2,000  rad) TNP-coupled syngeneic cells, and cultured as described for CI.LyI-N5. 
Cloning Procedure.  After 3-4 wk in culture, cells were distributed into microwells (Falcon 
microtiter plates 3040)  at final concentrations of 100, 10,  1, and 0.1 cells/well. In the case of 
CI.Lyl-T1, C1.Lyl-N5, and CI.Lyl-T3, each well contained 5 ×  105 irradiated syngeneic spleen 
cells in CDME, 25 #g/ml antigen and 2% IL-2; in the case of CI.Lyl-N1 and C1.Lyl-T6, each 
well  contained  5  ×  105  hapten-coupled  spleen  cells  in  CDME  and  2%  IL-2.  Wells were 
supplemented with CDME containing 2% IL-2 every 2 d. Positive wells were expanded and 
tested for antigen specificity by proliferation (see below) and recloned. All clones arose from 
wells seeded at < 1 cell/well (cloning efficiency >95%). 
Antigen-specific ~5.oliferation Assay.  1-4  ×  104  cloned cells were added  to  microtiter wells 
containing 5 ×  10  irradiated (2,000 rad) spleen cells in CDME and antigen as indicated. 24 h 
later, wells were pulsed with 2/~Ci [3H]thymidine and cultured for an additional 16 h. Cultures 
were harvested with a  Mash II (Microbiological Associates) and [3H]thymidine incorporation 
was measured using standard liquid scintillation counting techniques. Results are expressed as 
the mean of triplicate cultures. The standard deviation of each mean was < 10%. The effects of 
anti-hapten antisera and monoclonal anti-Ia antibodies were determined by adding dilutions 
of the antibodies to cultures at the initiation of the proliferation assay. 
Results 
Generation of Hapten-Reactive  T  Cell Clones.  Lymphocytes were  stimulated in  vitro 
with  the same hapten  used  for immunization coupled to a  different carrier protein 
(see  Materials  and  Methods).  To  minimize  nonspecific  or  polyclonal stimulation, 
these cultures were not supplemented with IL-2 for 4 wk before cloning. We generated 
>20 Thy-1 +, Ly-1  +, Ly-2,3-, Ig-, T  cell clones; their phenotype and specificity have 
been stable for >12 mo of in vitro culture. 
Conjugate-specific Clones.  The antigen specificity of four conjugate-specific clones is 
shown  in  Tables  I  and  II.  CI.Lyl-N5  and  C1.Lyl-T3  are  prototypes of one  set  of 
conjugate-specific clones that is activated by hapten coupled to soluble carrier protein. 
CI.Lyl-N5  incorporates  [3H]thymidine  in  the  presence  of NP-OVA,  the  conjugate 
used  for  initial expansion  of clonal  growth.  NP  coupled  to  all other  conventional 
proteins  tested,  including  closely related  proteins  such  as  turkey  albumin,  do  not 
activate the clone.  Similar specificity is shown  by C1.Lyl-T3.  In  short,  this class of 
inducers  is  activated by  hapten  associated with  a  unique  neighboring  amino  acid C
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sequence; recognition of both is essential for activation. The partial contribution of 
the hapten to the antigenic epitope fits with the observation that hapten analogues 
coupled to the appropriate  carrier protein can stimulate these clones. One of ~10 
clones raised to NP conjugates (CI.Lyl-N5) was activated by a  10-fold lower concen- 
tration of NIP-OVA  than NP-OVA;  maximum activation was achieved with 3  × 
10  -7 M  NIP compared with 2.5 ×  10  -6 M NP (Fig.  1). We have so far been unable to 
detect NP  b idiotypic determinants on this "heteroclitic" clone. 
Clones C1.Lyl-N1 and C1.Lyl-T6 are a  second subset of conjugate-specific clones 
that recognize haptenated determinants on cell surfaces rather than on soluble foreign 
proteins (Table II). CI.Lyl-N1 is activated by NP-coupled syngeneic spleen cells but 
not by NP coupled to soluble foreign proteins and a source ofAPC. CI.Lyl-T6, which 
also does not respond to soluble TNP conjugates, proliferates to TNP-coupled spleen 
cells from BALB/c and B10.D2 mice, indicating that non-MHC gene products are 
not involved. Thus, this subset of conjugate specific clones recognizes hapten only 
when it is conjugated to a  particular cell surface protein. In sum, conjugate-specific 
clones are activated by an epitope composed of hapten and a  unique sequence of 
associated amino acids on soluble proteins or autologous spleen cells. 
Hapten-specific Clones.  The hapten-specific clone C1.Lyl-T1 is activated by TNP 
conjugated to all carrier proteins tested, including autologous mouse proteins such as 
MSA (Fig. 2). The specificity of this clone for TNP is absolute: neither DNP nor NP 
coupled  to  a  variety of carriers  activates this clone  (Table  III).  C1.Lyl-T1  is  also 
activated  by hapten  coupled  to  syngeneic spleen  cells and  to  synthetic polymers. 
Analysis of reactivity with the latter carriers showed that the only carriers that failed 
to  stimulate were  polymers controlled by the  I-E,  rather  than  the  I-A,  locus  (see 
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FIG.  1.  Proliferative response of Ci.Lyl-N5 to hapten. 2  X  104 C1.Lyl-N5 and 5  X  105 irradiated 
C57BL/6 spleen ceils were added in 100/~1 of medium to microtiter wells. Hapten-carrier conjugates 
were normalized for hapten concentration and added at  the final concentrations indicated.  [aH] 
thymidine incorporation was measured on day 2. CLAYBERGER  ET  AL.  1911 
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FIG. 2.  Proliferative response of CI.Lyl-T1 to TNP-protein conjugates. 2 X  IO  4 CI.Lyl-T1 and 5 
×  105 irradiated BALB/c spleen cells were added in  100 #1 of medium to microtiter wells. TNP- 
protein conjugates were normalized for TNP and added at the final concentrations  indicated.  [SH] 
thymidine incorporation  was measured on day 2. A, TNPxs-BSA; O, TNP-GLA; 0, TNP~o-BGG; 
0, TNPga-MSA; [7, TNPls-MSA; m, TNP2x-KLH; &, TNP40-MIg. 
TABLE  III 
Antigen Specificity and 1-1-2 Recognition of Hapten-specific Clone 
Clone 
Antigen specificity* 
Antigen in culture 
Corecognition* 
Source of irradiated spleen cells 
cpm [ S  H]  thymidine incorporation 
CI.LyI-TI:  TNP-BGG  DNP-BGG  NP-BGG  FITC-BGG  BALB/c  B10.D2  D2.GD  A/J 
45,158  449  458  528  54,872  51,961  64,365  960 
* 2 X 104 clone plus 5 X 105 irradiated BALB/c spleen cells were incubated with 100 #g/ml of the indicated 
antigens. [SH]thymidine incorporation was measured on day 2. 
* 100 #g/ml of TNP-BGG was added to each well. See Table I for genetic composition of H-2 subregions. 
below). 
The Role of  Is + APC in Ir Gene Control.  Activation of both groups of clones required 
APC  from  donors  identical  at  the  I-A  locus  (Tables  I-III)  and  was  inhibited  by 
monoclonal  anti-I-A antibodies  (Fig.  3).  Restriction  by I-A was  further  confirmed 
using a  panel of Ir gene-controlled synthetic polymers. The  response  to  t-glutamic 
acid-t-lysine-t-alanine (GLA) is controlled by I-A gene products, whereas the response 
to  L-glutamic acid-L-lysine-t-phenylalanine (GLO),  L-glutamic acid-L-lysine-t-tyro- 
sine (GLT), and L-glutamic acid-t-lysine-L-leucine (GLLeu) is controlled by I-E gene 
products. CI.Lyl-T1 was activated by TNP-GLA  but not by TNP-GLO,  TNP-GLT, 
or TNP-GLLeu  (Table  IV).  The  failure to  respond to TNP-GLO,  TNP-GLT,  and 
TNP-GLLeu  was not a  result of I-E-controlled suppressor cells (8): CI.Ly 1-T 1 did not 
respond  to  TNP  coupled  to  GLO,  GLT,  or GLLeu  when  cells from  D2-GD  mice, 
which do not express I-E, were used as a  source of APC. The response to TNP-GLA 1912  TWO  CLASSES  OF HAPTEN-REACTIVE INDUCER  CELLS 
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FIc.  3.  Inhibition of proliferation of C1.Lyl-T1 by monoclonal anti-I-A. 2 ×  10' C1.Lyl-T1 and 5 
×  10  s irradiated BALB/c spleen cells were incubated with 50/~g/ml TNP-BGG.  MKD6 (O) or 
14.4.4S (O) were added at the indicated dilutions at the beginning of the culture.  [nH]thymidine 
incorporation was measured on day 2. 
TABLE  IV 
A.  Response of Cl.Ly l-T1 to Ir Gene-controlled  Synthetic Polypeptides* 
Controlled by:  I-A  I-E  I-E  ?  I-E 
Polymer:  TNP-GLA  TNP-GLO  TNP-GLT  TNP-GL  TNP-GLLeu 
B.  Test  for I-E Suppression 
Source of irradiated 
spleen ceils 
cpm [ a  H  ] thymidine incorporation 
290,363  2,389  4,208  4,455  4,579 
Balb/c  407,026  4,310  3,435  3,104  18,716 
D2.GD  319,108  3,998  4,822  1,997  29,431 
* 2 X 104 CI.Lyl-T1 plus 5 ×  10  a irradiated spleen cells were incubated with 20 ~g/ml of the indicated 
TNP-polymer conjugate. [aH]Thymidine incorporation was measured on day 2. 
was also not affected by addition of an equal concentration of TNP-GLO  (data not 
shown). 
Anti-hapten  Antibodies  Inhibit  Activation.  Many  attempts  to block activation of in- 
ducer T  cells by antibodies to  soluble antigen  have  failed  (9-13),  possibly because 
epitopes recognized by antibody are determined by secondary or tertiary structure or 
because  epitopes  defined  by  primary  structure  are  lost  during  antigen  processing. 
Hapten-reactive clones provide a  direct approach to this question  since the hapten, 
unlike protein determinants,  is not  likely to be structurally altered by "processing." 
Proliferation of both hapten and conjugate-specific clones was blocked (60%) by anti- 
hapten antibodies (Fig. 4). 
Evidence for a Conserved Domain of  the I-A Molecule that Directly Interacts with T Cells.  We 
tested the response of the hapten-specific clone C1.Ly 1-T 1 to TNP-coupled spleen cells 
from a  variety of mouse strains congenic at the MHC  locus. In contrast to the MHC- 
restricted response of this clone to  soluble antigen,  CI.Lyl-T1  is activated by TNP 
coupled to spleen cells expressing Ia  d'b'r'u's'f but  not Ia  k or q (Table V). The clone was CLAYBERGER  ET  AL.  1913 
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F/o.  4.  Inhibition of proliferation with anti-hapten antibodies. 2 X  104 CI.Lyl-N5 or C1.Lyl-T1 
were incubated with 5 ×  105 irradiated syngeneic feeder cells plus 20 p,g/ml NP-OVA or TNP-BGG 
respectively  (A) or with 5 ×  l0  b irradiated TNP coupled spleen cells "(A). Anti-hapten antisera were 
added at the indicated concentrations at the initiation of culture. [aH]thymidine incorporation was 
measured on day 2. 
TABLE  V 
Proliferation of Cl.Ly l-T1 to TNP-coupled Spleen Cells* 
Strain 
H-2 Subregions  [nH]thymidine 
K  A  B  J  E  C  S  G  D  Incorporation (cpm) 
B10.D2  d  d  d  d  d  d  d  d  d  191,094 
C57BL/10  b  b  b  b  b  b  b  b  b  126,586 
B10.RIII  r  r  r  r  r  r  r  r  r  188,142 
B10.PL  u  u  u  u  u  u  u  u  u  191,583 
B10.S  s  s  s  s  s  s  s  s  s  98,327 
C3H.LG  d  f  f  f  f  f  f  f  f  54,763 
B10.BR  k  k  k  k  k  k  k  k  k  6,965 
B10.G  q  q  q  q  q  q  q  q  q  1,318 
B10.A(4R)  k  k  b  b  b  b  b  b  b  1,439 
* 2 X 104 C1.Lyl-T1  plus 5 X  10  s irradiated, TNP-coupled spleen cells were incubated in medium. 
[aH]thymidine incorporation was measured on day 2. 
not activated by TNP  coupled to Ia negative cells such as the mastocytoma  cell line 
P815  or sheep erythrocytes (data not shown), suggesting that activation is restricted 
by  an  I  region  public  determinant  not  expressed by  the  k  and  q  haplotypes.  The 
ability of TNP  coupled to B 10 but not B10.A(4R)  cells to activate the clone mapped 
the response to the I-A region. C1.Lyl-T1  did not proliferate in cultures containing 
high  concentrations of soluble antigen and  allogenic APC,  nor was  it  activated by 1914  TWO  CLASSES  OF  HAPTEN-REACTIVE  INDUCER  CELLS 
direct coupling of allogenic cells with NP or FITC (data not shown). 
Discussion 
We have defined two classes of inducer clones based on specificity for haptens. One 
class, termed conjugate specific, represents the large majority of hapten-reactive cells. 
Clonal activation of this class requires restimulation by the same carrier protein used 
for  in  vitro  selection.  Specificity for hapten  is  less  stringent:  these  clones can  be 
activated, albeit less efficiently, by the carrier protein coupled with hapten analogues 
that  differ in  number,  position,  and  chemistry of substitution.  Conjugate-specific 
clones corecognize I-A and a particular amino acid sequence associated with hapten. 
The second class is termed hapten specific.  2 These clones arise much less frequently 
after immunization; only 2 of over 40 hapten-reactive clones were hapten specific. 
They  are  activated  by  hapten  coupled  to  any  carrier  protein  tested,  including 
autologous mouse proteins, and have stringent specificity for hapten; e.g., the TNP- 
specific clone CI.Lyl-T1 is not activated by DNP-protein  conjugates, even though 
TNP and DNP  differ only at the NO~  group at position six. This class of hapten- 
reactive T  inducer cell corecognizes I-A and hapten without any contribution from 
associated amino acids. (We cannot rule out contribution by lysine since all conjugates 
were prepared  using TNBS.)  Despite  the difference in  activation speeificities, it  is 
likely that these two classes of inducers mediate similar functions since C1.Lyl-T 1 and 
CI.Lyl-N5 express  the same major inducer-specific species of mRNA shortly after 
activation (14). 
Generation of hapten- or conjugate-specific T  cell clones depended on the protocol 
used  for immunization and  in vitro culture.  Stimulation by lightly or moderately 
conjugated proteins  routinely resulted  in  production  of conjugate-specific T  cells. 
Derivation  of hapten-specific clones  depended  on  (a)  immunization with  heavily 
haptenated  proteins  that  display  few  or  no  accessible  carrier  determinants,  (b) 
stimulation in vitro by conjugates of the same hapten coupled to a  different carrier 
protein, and (c) stimulation by conjugate-pulsed adherent cells to minimize exposure 
to uncoupled carrier determinants. 
Activation of both classes  of inducer clones by soluble protein-hapten conjugates 
requires antigen-presenting cells that express syngeneic I-A gene products, as shown 
using APC from mice differing at this locus, and by blocking with monoclonal anti-I- 
A  antibodies.  Activation  of the  subset  of conjugate-specific  clones  that  react  to 
haptenated spleen cells (e.g., CI.Lyl-N1 and CI.Lyl-T6) is also restricted by the I-A 
locus  and  inhibited  by  anti-I-A  antibodies  (data  not  shown).  We  have  not  yet 
established whether these ceils recognize hapten coupled to I-A itself (15) or to another 
cell surface protein (16) within the MHC locus. 
The repeated failure of antibodies directed against soluble antigen to block T  cell 
proliferation has led to two major hypotheses: (a) B cells and their secreted products, 
antibodies, recognize epitopes that differ from determinants recognized by inducer T 
cells  (17,  18);  and  (b)  antigen  processing  creates  new  determinants  that  are  not 
recognized by antibodies because of structural or conformational changes (9,  19, 20). 
We show that antibodies specific for epitopes that are not altered during processing 
2 Definition of inducer cells as hapten and conjugate specific refers to specificity of activation rather 
than  specificity of binding.  For  example,  isolated  hapten  may bind  to  conjugate-specific cells with  a 
measurable affinity, but this binding is not sufficient for activation. CLAYBERGER ET AL.  1915 
can block T  cell corecognition and activation by soluble antigen. Failure to block in 
other systems probably reflects technical problems of the sort described in alternative 
b. This finding also supports the possibility that antibody may specifically regulate 
the activation of an immune response by direct blocking of the stimulatory ligand 
(13, 21-23). 
Activation of inducer cells may be regulated at several discrete stages: antigen may 
not bind productively to I-A  + APC  (20, 24, 25);  it may not be processed to form a 
stimulatory I-A-antigen  complex  (26,  27);  the complex may not  be recognized by 
sufficient  numbers  of inducer  clones  (28);  or  it  may activate  inducer clones  that 
selectively stimulate suppressor cells rather than effector cells (29-31). Analysis of the 
ability of a  series of polymers and  proteins coupled to TNP to stimulate  a  TNP- 
specific inducer clone allowed a  direct test of (a)  whether interactions between the 
"nonresponder" proteins and I-A  + APC  account for certain types of I-A controlled 
unresponsiveness, or (b)  lack of response to I-A-controlled proteins reflects a  lack or 
defect  of specific  inducer  cells.  These  studies  demonstrate  two  lesions  in  T  cell 
responses to antigens controlled by the I-A locus. We first tested the possibility that 
the small group of  antigens exclusively under I-E control does not interact productively 
with  I-A molecules on APC.  This was  the case.  TNP-GLA, controlled by the I-A 
locus, caused a vigorous proliferative response; TNP coupled to the synthetic polymers 
GLO,  GLT,  and  GLLeu controlled  by I-E  genes  did  not.  Baxevanis  et  al.  have 
demonstrated  that  unresponsiveness  to  certain  antigens,  e.g.,  LDHB,  reflects  the 
presence of suppressor cells specific for antigen associated with I-E gene products (31). 
This does not account for the result reported here: stimulation by APC that lack I-E 
(D2.GD)  did not unmask a  proliferative response. Addition of TNP-GL~ to TNP- 
GLA-stimulated cultures also did not inhibit activation (data not shown). 
The second lesion is inferred from an analysis of the ability of autologous proteins 
(MSA)  and  proteins  controlled  by  I-A  genes  (MIg)  to  activate  C1.Lyl-T1.  Mice 
expressing the H-2  a haplotype are low- or nonresponders to both MSA and MIg (32). 
However, both proteins, when TNP conjugated,  induced a  strong response. Thus, 
unlike  I-E-controlled responses,  defective binding or processing of antigen  by I-A  + 
APC  per se does not account for I-A controlled low responsiveness. However, I-A  + 
APe may determine the portion of a protein that stimulates inducer clones both early 
in ontogeny and after immunization. Thus I-A+APC indirectly determine the numbers 
of inducer cell clones that corecognize a particular I-A-antigen complex. 
The hapten-specific clone CI.Lyl-T1 was activated by TNP coupled to spleen cells 
expressing Ia  b'a'~'~'v but not I-A  k'~. Pierres et al. observed a loss of MHC restriction in 
the  suppression  of cell-mediated  immunity  (33).  They accounted  for  this  by  re- 
processing of antigen by the recipient's own cells.  Reprocessing does not account for 
the finding reported here because clones had not been supplemented with irradiated 
syngeneic cells for over 3 wk;  they were not contaminated with functional APC, as 
judged by the complete lack of response to soluble antigen. TNP-coupled Ia negative 
cells did not stimulate CI.Lyl-T1, indicating that MHC genes were critical for such 
activation. This was  mapped to I-A using TNP-coupled cells from BI0.A(4R)  and 
B10 mice. The reaction was not simply the result of denaturation or production of 
mitogenic  factors  after TNP  conjugation:  spleen  cells  coupled  with  other  lysine- 
reactive reagents, such as NP and FITC, did not activate CI.Lyl-T1. Additionally, 
the response to TNP-coupled cells was blocked by anti-TNP antibody. These data 1916  TWO CLASSES  OF  HAPTEN-REACTIVE INDUCER  CELLS 
suggest  a  relatively conserved  domain  of the  I-A  molecule  that  may  be  directly 
recognized by T-cells as part of the I-A-hapten complex: TNP coupled to one set of 
I-A haplotypes 0o,r,u,v) mimics the T  cell epitope formed by TNP associated with I- 
A a, while hapten coupled to a second set of haplotypes (k,q) does not. This hypothesis 
receives  support  from  two  sources.  First,  comparison  of the  partial  amino  acid 
sequences of I-A from mice of the b, d, and k haplotypes shows that the AB chains 
from  H-2  d  and  H-2  b  are  highly  homologous,  whereas  there  is  significantly  less 
homology between H-2  d and H-2  k (34). Second, analyses of cell-mediated responses to 
TNP have indicated  that  inducer cells from H-2  b and  H-2  d mice both respond to 
TNP-coupled I-A  d cells, while inducer cells from mice expressing I-A  k gene products 
do not (35, 36). We are currently attempting to define this domain by serological and 
biochemical analysis. 
Inducer  cells  are  specialized  to  recognize antigen  associated  with  self-marking 
molecules. Once activated, they stimulate a panel of effector cells to mediate different 
forms of the immune response. This is a critical division of labor. Analyses of effector 
cells  have  shown  that  the  majority exhibit  hapten-specific rather  than  conjugate- 
specific recognition, as judged by studies of cytotoxic cells (37-39), B cells (40), and 
antibodies (41, 42). In contrast, hapten-specific inducer cells are extremely rare. The 
data presented have, as well as studies by others (43-45), demonstrate that the vast 
majority of inducer-cell clones recognize hapten in association with a defined sequence 
of amino  acids.  The  major consequence of this  conjugate-specific recognition  is  a 
highly stringent requirement for stimulation: inducer cells can be stimulated only by 
a  restricted set of proteins that carry the precise amino acid sequence of the original 
immunogen.  The  demonstration  that  almost  all  of the  individual  clones  carried 
receptors for a unique "conjugate-specific" amino acid sequence directly explains the 
"carrier effect" first observed by Gell and Benacerraf twenty years ago (46). 
The rare hapten-specific inducer cell, is stimulated promiscuously by a large array 
of proteins, including cell-bound or soluble autologous proteins, that carry the epitope 
or hapten.  Expansion of this clone occurs with continuous stimulation by the same 
determinant on different proteins, as shown here. Such clones may also be expanded 
in  situ  after continuous  exposure  to  viral  strains  that  carry  a  common  antigenic 
determinant. Inducer cells that bind to this determinant when it is covalently linked 
to autologous proteins, activate autoreactive effector cells via an  "antigen bridge." 
This is the case in vitro: hapten-specific inducer clones described in this report induce 
strong antibody responses to virtually any peptide coupled to the hapten (DeKruyff, 
R. H., C. Clayberger, and H. Cantor, manuscript submitted for publication). 
The consequences of this form of autoimmunity have apparently had a  powerful 
effect on  the  development  of the  inducer-cell  recognition  system:  hapten-specific 
clones are extremely rare.  However, as shown  here, these  inducer cells can  escape 
negative selection under special conditions. The biological activity of these cells in 
autoimmune disease, as well as their ability to be mobilized for active immunity to 
tumors deserves close analysis. 
Summary 
Hapten-reactive inducer T  cell clones can be divided into two groups based on 
their activation specificity. The first and  largest  group is conjugate specific. These 
clones are activated only by hapten coupled to the same carrier protein used for in CLAYBERGER  ET AL.  1917 
vitro selection. The second group, which is quite rare, is hapten specific. Clones of this 
type  are  activated  by hapten  coupled  to  all  foreign  and  autologus proteins  tested. 
Both types of clones corecognize soluble antigen  in association with products of the 
I-A locus. The hapten-specific cells were used to analyze the molecular basis of I-A vs. 
I-E gene control. The physiologic significance of hapten- and carrier-specific inducer 
T  cells in the response to foreign antigens and autoantigens is discussed. 
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